Skip to main content
236 search results for:

Gout 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 29-11-2022 | Gout | News | Article

    The metabolic syndrome may influence the risk for gout

    The metabolic syndrome may be a modifiable risk factor for incident gout, suggest findings from a nationwide study of more than 1.29 million men.

  2. 06-12-2022 | Gout | News | Article

    CA72-4 independently associated with gout flare risk in people initiating ULT

    Results from a prospective cohort study suggest that increased levels of serum CA72-4 at urate-lowering therapy initiation are an independent risk factor for recurrent gout flares.

  3. 06-10-2022 | Gout | News | Article
    News in brief

    SGLT2 inhibitors linked to lower gout risk than DPP-4 inhibitors

    SGLT2 inhibitors, a type of diabetes drug, are associated with a lower risk for gout than DPP-4 inhibitors, research suggests.

  4. 16-09-2022 | Gout | News | Article

    Gout risk factor prevalence may explain increased rates among Black Americans

    The higher prevalence of gout among Black men and women than their White counterparts is related to diet, social determinants of health, and chronic kidney disease, indicates research published in JAMA Network Open .

  5. 04-08-2022 | Gout | News | Article

    Gout flares linked to temporary increase in cardiovascular risk

    Gout flares are associated with an increased risk for cardiovascular events in the following 120 days, study findings suggest.

  6. 15-07-2022 | Gout | News | Article

    Study highlights sex-specific CVD risks in men with gout

    Regular allopurinol use and keeping serum urate levels within the target range may be associated with a reduced risk for cardiovascular events in men with gout and no history of cardiovascular disease, observational study findings indicate.

  7. 02-06-2022 | EULAR 2022 | Conference coverage | Article

    Topical alkalinizing treatment shows potential for acute gout

    A transdermal alkalinizing and pain-relieving treatment has been shown to effectively reduce the pain intensity and duration of an acute gout flare in the phase 2 TARGET study.

  8. 02-06-2022 | EULAR 2022 | Conference coverage | Article

    Methotrexate add-on therapy boosts pegloticase efficacy in refractory gout

    The addition of methotrexate to pegloticase for the treatment of uncontrolled gout improves the rate of sustained urate-lowering response over 6 months, show findings from the MIRROR randomized controlled trial.

  9. 05-05-2022 | Gout | News | Article

    Support for gout self-management for improving urate levels

    Supported self-management improves attainment of urate targets in people with gout, research suggests.

  10. 04-05-2022 | COVID-19 | News | Article
    News in brief

    Colchicine prophylaxis associated with ‘markedly reduced’ gout flare risk after COVID-19 vaccination

    COVID-19 vaccination with inactivated virus vaccines is associated with an increased risk for flares among men with gout, and colchicine prophylaxis may help reduce this risk, researchers report.

  11. 07-03-2022 | COVID-19 | News | Article

    Gout linked to increased risk for COVID-19 diagnosis, mortality

    People with gout, particularly women, may have an elevated risk for COVID-19 diagnosis and related death, suggest the results of a population-based study reported in The Lancet Rheumatology .

  12. 04-02-2022 | Gout | News | Article

    Healthy eating linked to reduced gout risk in women

    Adherence to one of four healthy eating patterns recommended in the 2020 to 2025 Dietary Guidelines for Americans is associated with a reduced risk for gout in women, Nurses’ Health Study findings indicate.

  13. 02-02-2022 | Gout | News | Article

    Gout linked to increased risk for lower extremity amputation

    Study findings suggest that men with gout, particularly those with poor serum urate control, may have an elevated risk for lower extremity amputation.

  14. 25-01-2022 | Gout | News | Article

    ​​​​​​​Allopurinol use not linked to increased mortality risk in people with gout, CKD

    Individuals with gout and concurrent chronic kidney disease are no more likely to die following allopurinol initiation, dose escalation, or achievement of target serum urate levels than those not taking the drug, study findings indicate.

  15. 06-11-2021 | ACR 2021 | Conference coverage | Article

    Data support serum urate-based treat-to-target approach in gout

    Serum urate concentration is a valid surrogate endpoint for the reduction or absence of gout flares, suggest study findings presented at the ACR Convergence 2021 virtual meeting and published in The Lancet Rheumatology.

  16. 09-11-2021 | ACR 2021 | Conference coverage | Article
    News in brief

    ​​​​​​​Reassurance on CV risk with treat-to-target strategies in gout

    Findings from an observational study designed to emulate a clinical trial suggest that treat-to-target serum urate-lowering strategies for gout are not associated with higher cardiovascular risk than less intensive approaches.

  17. 01-09-2021 | Gout | News | Article

    ELAG: Similar gout flare outcomes with early vs late allopurinol initiation

    Early initiation of allopurinol during an acute gout flare does not impact time to resolution or rates of recurrent flare, suggest findings from a randomized controlled trial.

  18. 05-06-2021 | EULAR 2021 | Conference coverage | Article
    News in brief 

    CV risk similar for gout treatments allopurinol and benzbromarone

    Allopurinol and benzbromarone have comparable cardiovascular risk profiles in patients with gout, suggests research presented in a poster at the EULAR 2021 Virtual Congress.

  19. 06-06-2021 | EULAR 2021 | Conference coverage | Article
    News in brief

    ​​​​​​​Genetic study points to causal link between gout and hypertension

    A Mendelian randomization analysis presented at the EULAR 2021 Virtual Congress suggests that the association between gout and hypertension may have a causal basis.

  20. 10-05-2021 | Temporal cell arteritis | Teaser

    Febuxostat and cardiovascular risk in people with gout

    How will the FAST trial results impact regulatory guidance & clinical practice?

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.